Canada says working with U.S. FDA to address EpiPen shortage

TORONTO (Reuters) - Canada's government health agency said on Tuesday it is working with the U.S. Food and Drug Administration to address a shortage of Mylan's EpiPen allergy antidote that his hit several countries outside of the United States, where it is manufactured.